SOHO 2023 Eleventh Annual Meeting
Leukemia
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CML and Pregnancy
FEATURING
Elisabetta Abruzzese
- 73 views
- November 21, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: AML
FEATURING
Farhad Ravandi
- 124 views
- October 25, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
CLL: Next Questions
FEATURING
Nitin Jain
- 454 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: CML
FEATURING
Philippe Rousselot
- 27 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
Next Questions in ALL
FEATURING
Elias Jabbour
- 178 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is New in the WHO Classification of AML?
FEATURING
Sanam Loghavi
- 59 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is New in the ICC Classification of AML?
FEATURING
Robert Paul Hasserjian
- 38 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: How Do We Reconcile These AML Classifications in Clinical Management and Research?
FEATURING
Andrew Wei
- 26 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 DEBATE: Prior Therapy Not Needed for Transplanting Patients With R/R AML
FEATURING
Johannes Schetelig
- 21 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Familial Predisposition to AML: Prevalence & Implications for Management
FEATURING
Lucy Godley
- 35 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Impact of Consolidation Chemo Intensity Before Allogeneic HSCT in Elderly Patients With AML
FEATURING
Yosr Hicheri
- 18 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 DEBATE: Patients With AML and Active Disease Should Be Transplanted
FEATURING
Hugo F. Fernandez
- 110 views
- October 19, 2023
- 4
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Genomic Complexity Beyond BCR::ABL1 and Its Clinical Impact
FEATURING
David Ross
- 25 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Epigenetic Dysregulation of CML
FEATURING
Tiong Ong
- 31 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: The New ELN Laboratory Recommendations for the Diagnosis and Management of CML
FEATURING
Nick Cross
- 430 views
- October 18, 2023
- 3
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: How Biologic Markers Impact CLL Outcomes With Novel Therapy
FEATURING
Talha Munir
- 67 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Clinical Significance of MBL
FEATURING
Sameer Parikh
- 19 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is the Future of Menin Inhibitors in AML?
FEATURING
Ghayas Issa
- 174 views
- October 18, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CNS Prophylaxis in ALL
FEATURING
Partow Kebriaei
- 33 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Sequencing Immunotherapies in Adults With B-ALL
FEATURING
Bijal Shah
- 48 views
- October 18, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Updates on the Role of SCT in ALL in the Era of CAR-T
FEATURING
Jae Park
- 83 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Triplet Regimens in AML: Beyond Azacitidine + Venetoclax
FEATURING
Courtney D. DiNardo
- 384 views
- October 16, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Navigating the Treatment Value of TKIs in CML in the Era of Generics
FEATURING
Hagop Kantarjian
- 37 views
- October 13, 2023
SOHO 2023 Eleventh Annual Meeting
Liso-Cel in R/R CLL/SLL: Primary Analysis of the Phase 1/2, Single-Arm, Multicenter TRANSCEND CLL 004 Study
FEATURING
Tanya Siddiqi
- 116 views
- October 10, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Rational TKI Choice in CML
FEATURING
Michael Deininger
- 309 views
- October 9, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: How We Developed a Curative Therapy for CLL and Stopped Using It
FEATURING
John Seymour
- 17 views
- October 9, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Is Finite Duration Therapy the New Standard of Treatment in Frontline CLL?
FEATURING
Alessandra Ferrajoli
- 236 views
- October 6, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Debate: MRD+ After 1 Year of VenG in CLL - Stop or Continue Therapy?
FEATURING
Othman Al-Sawaf,
Nicole Lamanna
- 73 views
- October 6, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CML - Are We Doing It Right?
FEATURING
Jorge Cortés
- 351 views
- October 6, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Slow-Motion Therapeutic Revolution in Adult ALL
FEATURING
Hagop Kantarjian
- 101 views
- October 6, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Is AML With Monocytic Features a Separate Entity?
FEATURING
Daniel Pollyea
- 138 views
- October 6, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is the Role of Quizartinib in the Current Landscape of Initial AML Therapy?
FEATURING
Harry P. Erba
- 69 views
- October 5, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 First Report of Phase 3 PhALLCON Study: Comparing Ponatinib vs. Imatinib in Newly Diagnosed Ph+ ALL
FEATURING
Elias Jabbour
- 117 views
- October 4, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Acute Leukemia of Ambiguous Lineage
FEATURING
Caner Saygin
- 119 views
- September 29, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Management of Newly Diagnosed Ph+ ALL: Novel Drugs and Strategies
FEATURING
Elias Jabbour
- 42 views
- September 29, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Menin Inhibition for KMT2A-Rearranged ALL
FEATURING
Eytan Stein
- 39 views
- September 29, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Approach to Ph-Like ALL
FEATURING
Ilaria Iacobucci
- 147 views
- September 29, 2023
- 1